The FDA indicated in its fall regulatory agenda that it could unveil a drug importation proposal next month following President Donald Trump's announcement that he plans to allow state governments to buy cheaper drugs from Canada. The proposal is facing resistance from US drugmakers, and Kirsten Hillman, Canada's acting ambassador to the US, said the country's drug industry is too small to supply cheaper medicines to the US.
FDA could release drug importation plan in January
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.